Epcoritamab

ATC L01FX27 · 10 markets · 22 records

Epcoritamab 10 markets · 22 records Forms

AU 5 records · 5 strengths

  • 4 mg/0.8 mLinjectionEPKINLY also in US·GB·SG +2
  • 48 mg/0.8 mLinjectionEPKINLY also in US·GB·SG +1
  • 60 mg/mLinjectionEPKINLY epcoritamab 48mg/0.8mL solution for injection vial unknown
  • 5 mg/mLinjectionEPKINLY epcoritamab 4mg/0.8mL concentrate solution for injection vial unknown

Records without a stated strength · 1 EPKINLY

HK 3 records · 1 strengths

    Records without a stated strength · 1 EPKINLY CONCENTRATE FOR SOLUTION FOR INJECTION 4MG/0.8ML、EPKINLY Solution for Injection 48 mg/0.8 mL

    US 2 records · 2 strengths

    GB 2 records · 2 strengths

    • 4 mg/0.8 mLinjectionTepkinly 4mg/0.8ml concentrate for solution for injection vials also in AU·US·SG +2
    • 48 mg/0.8 mLinjectionTepkinly 48mg/0.8ml solution for injection vials also in AU·US·SG +1

    CA 2 records · 2 strengths

    SG 2 records · 2 strengths

    ES 2 records · 2 strengths

    TW 2 records · 2 strengths

    MX 1 records · 1 strengths

      Records without a stated strength · 1 EPKINLY

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 TEPKINLY

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.